Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ni-catalyzed route for chiral nafoxidine-3-carboxylic acid. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN114181080B enables green synthesis of Indoxacarb intermediate with water solvent, offering cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN1842523A details a novel asymmetric hydrogenation process for enantiomerically pure beta-amino alcohols, offering significant cost reduction in API manufacturing.
Patent CN102952001A offers cost-effective chiral intermediate production. Enhances supply chain reliability for Lurasidone manufacturing.
Advanced asymmetric oxidation process for high-purity Esomeprazole Sodium. Reduces impurities and enhances supply chain stability for global pharmaceutical manufacturers.
Patent CN106008611B details a novel chiral cobalt complex enabling high conversion Henry reactions with simplified synthesis for reliable supply chains.
Patent CN109942514B details a cost-effective L-phenylalanine route for Atazanavir intermediates, offering high purity and scalable manufacturing solutions.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel Ru-BINAP catalyzed route for (R)-5'-methoxylaudanosine. High purity >99.98% ee, non-genotoxic process, scalable for Mivacurium Chloride production.
Patent CN113666915B reveals a novel 5-step route for posaconazole intermediates using chiral iron catalysis, offering high purity and scalable manufacturing for global supply chains.
Patent CN1923792A reveals a cost-effective synthesis for HMG-CoA reductase inhibitor intermediates, offering scalable production and superior optical purity for global supply chains.
Novel Rh-catalyzed asymmetric hydrogenation route for Pramipexole. Higher yield, lower cost, industrial scale ready. Ideal for pharma intermediates.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel BCl3 catalyzed route improves yield and safety for SGLT2 inhibitor manufacturing supply chain reliability and cost efficiency significantly for global buyers.
Patent CN105189524A enables high-yield chiral amino acid production with recoverable auxiliaries for scalable pharmaceutical manufacturing supply chains and cost-effective commercialization strategies.
Patent CN103003257B details a one-step L-carnitine synthesis. Offers high purity, cost reduction, and supply chain reliability for pharmaceutical intermediates.
Patent CN101429192A details a novel chiral titanium catalysis method for high-purity proton pump inhibitor intermediates, offering significant supply chain and cost advantages.
Patent CN102977076A reveals a high-purity R-lansoprazole synthesis using chiral titanium catalysis. Discover cost-effective manufacturing insights for pharmaceutical supply chains.
Novel chiral phosphoric acid catalysis method offers high yield and mild conditions for scalable pharmaceutical intermediate manufacturing supply chain optimization and cost efficiency.